Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice.

Kitanaka, Nobue; Kitanaka, Junichi; Tatsuta, Tomohiro; Tanaka, Koh-ichi; Watabe, Kaname; Nishiyama, Nobuyoshi; Morita, Yoshio; Takemura, Motohiko

Kitanaka, Nobue; Kitanaka, Junichi; Tatsuta, Tomohiro; Tanaka, Koh-ichi; Watabe, Kaname; Nishiyama, Nobuyoshi; Morita, Yoshio; Takemura, Motohiko.

Affiliation

Kitanaka N; Department of Pharmacology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

Neurochem Res ; 35(5): 749-60, 2010 May.

Article in En | MEDLINE | ID: mdl-20148307

Subject(s)

Amphetamine-Related Disorders/metabolism; Anxiety/chemically induced; Behavior, Animal/drug effects; Methamphetamine/adverse effects; Methoxyhydroxyphenylglycol/metabolism; Substance Withdrawal Syndrome/metabolism; Animals; Brain Chemistry/drug effects; Disease Models, Animal; Male; Methamphetamine/administration & dosage; Mice; Mice, Inbred ICR

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Anxiety / Substance Withdrawal Syndrome / Behavior, Animal / Amphetamine-Related Disorders / Methamphetamine / Methoxyhydroxyphenylglycol Limits: Animals Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google